Advanced search
Publication Cover
Emerging Microbes & Infections Volume 11, 2022 - Issue 1
Submit an article Journal homepage
2,739
Views
7
CrossRef citations to date
0
Altmetric
Coronaviruses

An engineered 5-helix bundle derived from SARS-CoV-2 S2 pre-binds sarbecoviral spike at both serological- and endosomal-pH to inhibit virus entry

Xi Lina West China Hospital Emergency Department (WCHED), State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, People’s Republic of ChinaView further author information
,
Liyan Guoa West China Hospital Emergency Department (WCHED), State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, People’s Republic of ChinaView further author information
,
Sheng Lina West China Hospital Emergency Department (WCHED), State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, People’s Republic of ChinaView further author information
,
Zimin Chena West China Hospital Emergency Department (WCHED), State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, People’s Republic of ChinaView further author information
,
Fanli Yanga West China Hospital Emergency Department (WCHED), State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, People’s Republic of ChinaView further author information
,
Jing Yanga West China Hospital Emergency Department (WCHED), State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, People’s Republic of ChinaView further author information
,
Lingling Wanga West China Hospital Emergency Department (WCHED), State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, People’s Republic of ChinaView further author information
,
Ao Wena West China Hospital Emergency Department (WCHED), State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, People’s Republic of ChinaView further author information
,
Yanping Duana West China Hospital Emergency Department (WCHED), State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, People’s Republic of ChinaView further author information
,
Xindan Zhanga West China Hospital Emergency Department (WCHED), State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, People’s Republic of ChinaView further author information
,
Yushan Daia West China Hospital Emergency Department (WCHED), State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, People’s Republic of ChinaView further author information
,
Keqing Yina West China Hospital Emergency Department (WCHED), State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, People’s Republic of ChinaView further author information
,
Xin Yuana West China Hospital Emergency Department (WCHED), State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, People’s Republic of ChinaView further author information
,
Chongzhang Yua West China Hospital Emergency Department (WCHED), State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, People’s Republic of ChinaView further author information
,
Bin Hea West China Hospital Emergency Department (WCHED), State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, People’s Republic of ChinaView further author information
,
Yu Caoa West China Hospital Emergency Department (WCHED), State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, People’s Republic of China;b Disaster Medicine Center, West China Hospital, Sichuan University, Chengdu, People’s Republic of ChinaView further author information
,
Haohao Dongc Laboratory of Aging Research and Cancer Drug Target, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, People’s Republic of ChinaView further author information
,
Jian Lid School of Basic Medical Sciences, Chengdu University, Chengdu, People’s Republic of ChinaView further author information
,
Qi Zhaoe College of Food and Biological Engineering, Chengdu University, Chengdu, People’s Republic of ChinaView further author information
&
Guangwen Lua West China Hospital Emergency Department (WCHED), State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, People’s Republic of ChinaCorrespondence[email protected]
View further author information
 show all
Pages 1920-1935 | Received 24 May 2022, Accepted 23 Jun 2022, Published online: 05 Aug 2022

References

  • Ke Z, Oton J, Qu K, et al. Structures and distributions of SARS-CoV-2 spike proteins on intact virions. Nature. 2020 Dec;588(7838):498–502. doi:10.1038/s41586-020-2665-2. PubMed PMID: 32805734; PubMed Central PMCID: PMCPMC7116492.
  • Cai Y, Zhang J, Xiao T, et al. Distinct conformational states of SARS-CoV-2 spike protein. Science. 2020 Sep 25;369(6511):1586–1592. doi:10.1126/science.abd4251. PubMed PMID: 32694201; PubMed Central PMCID: PMCPMC7464562.
  • Shang J, Ye G, Shi K, et al. Structural basis of receptor recognition by SARS-CoV-2. Nature. 2020 May;581(7807):221–224. doi:10.1038/s41586-020-2179-y. PubMed PMID: 32225175; PubMed Central PMCID: PMC7328981.
  • Lan J, Ge J, Yu J, et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature. 2020 May;581(7807):215–220. doi:10.1038/s41586-020-2180-5. PubMed PMID: 32225176.
  • Yang J, Wang W, Chen Z, et al. A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity. Nature. 2020 Oct;586(7830):572–577. doi:10.1038/s41586-020-2599-8. PubMed PMID: 32726802.
  • Chen RE, Zhang X, Case JB, et al. Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies. Nat Med. 2021 Apr;27(4):717–726. doi:10.1038/s41591-021-01294-w. PubMed PMID: 33664494; PubMed Central PMCID: PMC8058618.
  • Yewdell JW. Antigenic drift: understanding COVID-19. Immunity. 2021 Dec 14;54(12):2681–2687. doi:10.1016/j.immuni.2021.11.016. PubMed PMID: 34910934; PubMed Central PMCID: PMC8669911.
  • Yuan M, Huang D, Lee CD, et al. Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants. Science (New York, NY). 2021 Aug 13;373(6556):818–823. doi:10.1126/science.abh1139. PubMed PMID: 34016740; PubMed Central PMCID: PMC8284396.
  • Planas D, Saunders N, Maes P, et al. Considerable escape of SARS-CoV-2 Omicron to antibody neutralization. Nature. 2021 Dec 23. doi:10.1038/s41586-021-04389-z. PubMed PMID: 35016199.
  • Wang Z, Schmidt F, Weisblum Y, et al. mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants. Nature. 2021 Apr;592(7855):616–622. doi:10.1038/s41586-021-03324-6. PubMed PMID: 33567448; PubMed Central PMCID: PMC8503938.
  • Liu C, Ginn HM, Dejnirattisai W, et al. Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum. Cell. 2021 Aug 5;184(16):4220–4236. e13. doi:10.1016/j.cell.2021.06.020. PubMed PMID: 34242578; PubMed Central PMCID: PMC8218332.
  • Gobeil SM, Janowska K, McDowell S, et al. Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity. Science (New York, NY). 2021 Aug 6;373(6555). doi:10.1126/science.abi6226. PubMed PMID: 34168071; PubMed Central PMCID: PMC8611377.
  • Hoffmann M, Arora P, Gross R, et al. SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies. Cell. 2021 Apr 29;184(9):2384–2393. e13. doi:10.1016/j.cell.2021.03.036. PubMed PMID: 33794143; PubMed Central PMCID: PMC7980144.
  • Hoffmann M, Kruger N, Schulz S, et al. The Omicron variant is highly resistant against antibody-mediated neutralization: implications for control of the COVID-19 pandemic. Cell. 2022 Feb 3;185(3):447–456. e11. doi:10.1016/j.cell.2021.12.032. PubMed PMID: 35026151; PubMed Central PMCID: PMC8702401.
  • Cao Y, Wang J, Jian F, et al. Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies. Nature. 2021 Dec 23. doi:10.1038/s41586-021-04385-3. PubMed PMID: 35016194.
  • Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020 Mar;579(7798):270–273. doi:10.1038/s41586-020-2012-7. PubMed PMID: 32015507; PubMed Central PMCID: PMC7095418.
  • Lam TT, Jia N, Zhang YW, et al. Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins. Nature. 2020 Jul;583(7815):282–285. doi:10.1038/s41586-020-2169-0. PubMed PMID: 32218527.
  • Xiao K, Zhai J, Feng Y, et al. Isolation of SARS-CoV-2-related coronavirus from Malayan pangolins. Nature. 2020 Jul;583(7815):286–289. doi:10.1038/s41586-020-2313-x. PubMed PMID: 32380510.
  • Cameroni E, Bowen JE, Rosen LE, et al. Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift. Nature. 2021 Dec 23. doi:10.1038/s41586-021-04386-2. PubMed PMID: 35016195.
  • McCallum M, Bassi J, De Marco A, et al. SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern. Science (New York, NY). 2021 Aug 6;373(6555):648–654. doi:10.1126/science.abi7994. PubMed PMID: 34210893.
  • Harvey WT, Carabelli AM, Jackson B, et al. SARS-CoV-2 variants, spike mutations and immune escape. Nat Rev Microbiol. 2021 Jul;19(7):409–424. doi:10.1038/s41579-021-00573-0. PubMed PMID: 34075212; PubMed Central PMCID: PMCPMC8167834.
  • Hu B, Guo H, Zhou P, et al. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021 Mar;19(3):141–154. doi:10.1038/s41579-020-00459-7. PubMed PMID: 33024307; PubMed Central PMCID: PMC7537588.
  • Wrapp D, Wang N, Corbett KS, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020 Mar 13;367(6483):1260–1263. doi:10.1126/science.abb2507. PubMed PMID: 32075877; PubMed Central PMCID: PMCPMC7164637.
  • Walls AC, Tortorici MA, Snijder J, et al. Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion. Proc Natl Acad Sci U S A. 2017 Oct 17;114(42):11157–11162. doi:10.1073/pnas.1708727114. PubMed PMID: 29073020; PubMed Central PMCID: PMCPMC5651768.
  • Fan X, Cao D, Kong L, et al. Cryo-EM analysis of the post-fusion structure of the SARS-CoV spike glycoprotein. Nat Commun. 2020 Jul 17;11(1):3618. doi:10.1038/s41467-020-17371-6. PubMed PMID: 32681106; PubMed Central PMCID: PMCPMC7367865.
  • Liu S, Xiao G, Chen Y, et al. Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors. Lancet. 2004 Mar 20;363(9413):938–947. doi:10.1016/S0140-6736(04)15788-7. PubMed PMID: 15043961; PubMed Central PMCID: PMCPMC7140173.
  • Lu L, Liu Q, Zhu Y, et al. Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor. Nat Commun. 2014;5:3067. doi:10.1038/ncomms4067. PubMed PMID: 24473083; PubMed Central PMCID: PMC7091805.
  • Xia S, Zhu Y, Liu M, et al. Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein. Cell Mol Immunol. 2020 Jul 17;17(7):765–767. doi:10.1038/s41423-020-0374-2. PubMed PMID: 32047258; PubMed Central PMCID: PMCPMC7075278.
  • Xia S, Yan L, Xu W, et al. A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike. Sci Adv. 2019 Apr;5(4). eaav4580. doi:10.1126/sciadv.aav4580. PubMed PMID: 30989115; PubMed Central PMCID: PMCPMC6457931.
  • Pinto D, Sauer MM, Czudnochowski N, et al. Broad betacoronavirus neutralization by a stem helix-specific human antibody. Science. 2021 Sep 3;373(6559):1109–1116. doi:10.1126/science.abj3321. PubMed PMID: 34344823.
  • Wang C, van Haperen R, Gutierrez-Alvarez J, et al. A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies. Nat Commun. 2021 Mar 17;12(1):1715), doi:10.1038/s41467-021-21968-w. PubMed PMID: 33731724; PubMed Central PMCID: PMC7969777.
  • Root MJ, Kay MS, Kim PS. Protein design of an HIV-1 entry inhibitor. Science. 2001 Feb 2;291(5505):884–888. doi:10.1126/science.1057453. PubMed PMID: 11229405.
  • Sun Y, Zhang H, Shi J, et al. Identification of a novel inhibitor against Middle East Respiratory Syndrome coronavirus. Viruses. 2017 Sep 14;9(9). doi:10.3390/v9090255. PubMed PMID: 28906430; PubMed Central PMCID: PMCPMC5618021.
  • Xia S, Liu M, Wang C, et al. Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion. Cell Res. 2020 Apr;30(4):343–355. doi:10.1038/s41422-020-0305-x. PubMed PMID: 32231345; PubMed Central PMCID: PMCPMC7104723.
  • Jiang X, Zhang Z, Wang C, et al. Bimodular effects of D614G mutation on the spike glycoprotein of SARS-CoV-2 enhance protein processing, membrane fusion, and viral infectivity. Signal Transduction and Targeted Therapy. 2020 Nov 17;5(1):268. doi:10.1038/s41392-020-00392-4. PubMed PMID: 33203835; PubMed Central PMCID: PMC7670837.
  • Korber B, Fischer WM, Gnanakaran S, et al. Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell. 2020 Aug 20;182(4):812–827. e19. doi:10.1016/j.cell.2020.06.043. PubMed PMID: 32697968; PubMed Central PMCID: PMC7332439.
  • McCallum M, Walls AC, Bowen JE, et al. Structure-guided covalent stabilization of coronavirus spike glycoprotein trimers in the closed conformation. Nat Struct Mol Biol. 2020 Oct;27(10):942–949. doi:10.1038/s41594-020-0483-8. PubMed PMID: 32753755; PubMed Central PMCID: PMCPMC7541350.
  • Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and Is blocked by a clinically proven protease inhibitor. Cell. 2020 Apr 16;181(2):271–280. e8. doi:10.1016/j.cell.2020.02.052. PubMed PMID: 32142651; PubMed Central PMCID: PMCPMC7102627.
  • Wang R, Zhang Q, Ge J, et al. Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species. Immunity. 2021 Jul 13;54(7):1611–1621. e5. doi:10.1016/j.immuni.2021.06.003. PubMed PMID: 34166623; PubMed Central PMCID: PMCPmc8185182. eng.
  • He X, Hong W, Pan X, et al. SARS-CoV-2 Omicron variant: Characteristics and prevention. MedComm. 2020. 2021 Dec 16. doi:10.1002/mco2.110. PubMed PMID: 34957469; PubMed Central PMCID: PMCPMC8693031.
  • Ye F, Lin X, Chen Z, et al. S19w, T27W, and N330Y mutations in ACE2 enhance SARS-CoV-2 S-RBD binding toward both wild-type and antibody-resistant viruses and its molecular basis. Signal Transduct Target Ther. 2021 Sep 16;6(1):343. doi:10.1038/s41392-021-00756-4. PubMed PMID: 34531369; PubMed Central PMCID: PMCPMC8444507.
  • Lin S, Chen Z, Zhang X, et al. Characterization of SARS-CoV-2 Omicron spike RBD reveals significantly decreased stability, severe evasion of neutralizing-antibody recognition but unaffected engagement by decoy ACE2 modified for enhanced RBD binding. Signal Transduction and Targeted Therapy. 2022 Feb 21;7(1):56. doi:10.1038/s41392-022-00914-2. PubMed PMID: 35190526; PubMed Central PMCID: PMC8860268.
  • Sun H, Li Y, Liu P, et al. Structural basis of HCoV-19 fusion core and an effective inhibition peptide against virus entry. Emerg Microbes Infect. 2020 Dec;9(1):1238–1241. doi:10.1080/22221751.2020.1770631. PubMed PMID: 32482145; PubMed Central PMCID: PMCPMC7448930.
  • Xing L, Xu X, Xu W, et al. A five-helix-based SARS-CoV-2 fusion inhibitor targeting heptad repeat 2 domain against SARS-CoV-2 and Its variants of concern. Viruses. 2022 Mar 13;14(3). doi:10.3390/v14030597. PubMed PMID: 35337003; PubMed Central PMCID: PMC8955665.
  • Latinne A, Hu B, Olival KJ, et al. Origin and cross-species transmission of bat coronaviruses in China. Nat Commun. 2020 Aug 25;11(1):4235. doi:10.1038/s41467-020-17687-3. PubMed PMID: 32843626; PubMed Central PMCID: PMC7447761.
  • Liu K, Pan X, Li L, et al. Binding and molecular basis of the bat coronavirus RaTG13 virus to ACE2 in humans and other species. Cell. 2021 Jun 24;184(13):3438–3451. e10. doi:10.1016/j.cell.2021.05.031. PubMed PMID: 34139177; PubMed Central PMCID: PMCPMC8142884.
  • Zhang S, Qiao S, Yu J, et al. Bat and pangolin coronavirus spike glycoprotein structures provide insights into SARS-CoV-2 evolution. Nat Commun. 2021 Mar 11;12(1):1607. doi:10.1038/s41467-021-21767-3. PubMed PMID: 33707453; PubMed Central PMCID: PMCPMC7952905.
  • Zhou T, Tsybovsky Y, Gorman J, et al. Cryo-EM structures of SARS-CoV-2 spike without and with ACE2 reveal a pH-dependent switch to mediate endosomal positioning of receptor-binding domains. Cell Host Microbe. 2020 Dec 9;28(6):867–879. e5. doi:10.1016/j.chom.2020.11.004. PubMed PMID: 33271067; PubMed Central PMCID: PMCPMC7670890.
  • Zhu J, Jiang X, Liu Y, et al. Design and characterization of viral polypeptide inhibitors targeting Newcastle disease virus fusion. J Mol Biol. 2005 Dec 2;354(3):601–613. doi:10.1016/j.jmb.2005.08.078. PubMed PMID: 16253271; PubMed Central PMCID: PMCPMC7094301.
  • Chan KK, Dorosky D, Sharma P, et al. Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2. Science. 2020 Sep 4;369(6508):1261–1265. doi:10.1126/science.abc0870. PubMed PMID: 32753553; PubMed Central PMCID: PMCPMC7574912.
  • Lei C, Qian K, Li T, et al. Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig. Nat Commun. 2020 Apr 24;11(1):2070), doi:10.1038/s41467-020-16048-4. PubMed PMID: 32332765; PubMed Central PMCID: PMCPMC7265355.
  • Zhang W-Z, Tang J-C, Wang S-S, et al. The protein complex crystallography beamline (BL19U1) at the Shanghai Synchrotron Radiation facility. Nucl Sci Tech. 2019 2019 Oct 28;30(11):170), doi:10.1007/s41365-019-0683-2.
  • Otwinowski Z, Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 1997;276:307–326. PubMed PMID: 27754618.
  • Read RJ. Pushing the boundaries of molecular replacement with maximum likelihood. Acta Crystallogr D Biol Crystallogr. 2001 Oct;57(Pt 10):1373–1382. doi:10.1107/s0907444901012471. PubMed PMID: 11567148.
  • Collaborative Computational Project N. The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr. 1994 Sep 1;50(Pt 5):760–763. doi:10.1107/S0907444994003112. PubMed PMID: 15299374.
  • Murshudov GN, Vagin AA, Dodson EJ. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr. 1997 May 1;53(Pt 3):240–255. doi:10.1107/S0907444996012255. PubMed PMID: 15299926.
  • Terwilliger TC, Grosse-Kunstleve RW, Afonine PV, et al. Iterative model building, structure refinement and density modification with the PHENIX AutoBuild wizard. Acta Crystallogr D Biol Crystallogr. 2008 Jan;64(Pt 1):61–69. doi:10.1107/S090744490705024X. PubMed PMID: 18094468; PubMed Central PMCID: PMCPMC2394820.
  • Laskowski RA, Rullmannn JA, MacArthur MW, et al. AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J Biomol NMR. 1996 Dec;8(4):477–486. doi:10.1007/BF00228148. PubMed PMID: 9008363.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.